The New Oral Medications: Questions for Your Healthcare Provider
The new oral medications, including the recently approved drug Gilenya, have the advantage of not requiring injections or infusions, as with drugs approved prior to September 2010. Additionally, oral drugs might not be associated with some of the side effects of the earlier drugs, including flu-like reactions. But these new drugs are not without potential side effects and adverse events, which need to be discussed with your healthcare provider prior to making any treatment decisions.
If you are considering whether you should change to an oral medication, ask your doctor the following questions:
All of the disease-modifying therapies for MS have different benefits and risks. Choosing a treatment is a very individualized decision, so your best plan of action is to develop a partnership with your doctor and to gather as much information as possible.
|Last Updated on Monday, 25 March 2013 12:31|